Intuitive Surgical, Inc. (BVMF:I1SR34)

Market Cap	904.84B -29.5%
Revenue (ttm)	55.44B +20.5%
Net Income	15.73B +23.0%
EPS	43.35 +22.6%
Shares Out	n/a
PE Ratio	57.52
Forward PE	47.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Average Volume	1,177
Open	127.40
Previous Close	126.88
Day's Range	127.40 - 127.40
52-Week Range	114.00 - 174.25
Beta	1.66
RSI	27.19
Earnings Date	Jan 21, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1995
• Employees: 15,638
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: I1SR34

Financial Performance

In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.

Financial numbers in USD